A single tumor harbored a TERT promoter mutation, an alteration associated with poor prognosis and consistent a CNS WHO grade 3 designation within the updated 2021 WHO Classification of CNS tumors.2 This patient remains alive, with multiple tumor recurrences 15 years after the initial diagnosis. Here, TERT is linked to central nervous system neoplasm.